Arq ajwain protects nonalcoholic fatty liver disease on high-fat diet-induced obese rat

Subject Areas : Ethnopharmacology

Md Rafiul Haque ¹ (School of Pharmacy, Al-Karim University, Bihar, India|School of Pharmaceutical Education and Research, Hamdard University, Hamdard Nagar, New Delhi 62, India)
Md Afroz Ahmad ² (Department of Prmhacology, Integral University, Lucknow (U.P), India)
Kamran Ashraf ³ (Faculty of Pharmacy, University Teknologi MARA (UITM), Cawangan Selangor, Kampus Puncak Alam, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malasiya)
Md Habban Akhter ⁴ (School of Pharmaceutical and population Health information (SoPPHI), DIT University, Dehradun 248009, India)
Mohammad Jameel ⁵ (RRIUM, CCRUM Aligarh (UP), India)
Abuzer Ali ⁶ (Department of Pharmacognosy, College of Pharmacy, Taif University, P.O. box 21944, Saudi Arabia)
Wasim Akhtar ⁷ (School of Pharmacy, Al-Karim University, Bihar, India)
Monika Dhaka ⁸ (School of Pharmaceutical and population Health information (SoPPHI), DIT University, Dehradun 248009, India)
Kavita Rana ⁹ (Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida (UP), India)

Received: 2021-09-17 Accepted : 2021-12-11 Published : 2021-12-01

Keywords: Ajwain, insulin, Oxidative stress, Leptin, Nonalcoholic fatty liver disease,

Abstract :

In the present study, we investigated the safety and therapeutic efficacy of arq ajwain (AA) against nonalcoholic fatty liver disease (NAFLD) on a high-fat diet (HFD) induced obese rat model. After 4 weeks of the treatment, AA (4 mL/kg, twice a day) and AA1 (7.75 mL/kg, twice a day) treatments reduced body weight, serum triglycerides (TG), total cholesterol (TG), glucose, insulin, leptin, pancreatic lipase activity and alanine aminotransferase (ALT) levels (p < 0.001). AA, AA1, and thymol (T) treatments also decreased lipids (TG and TC) levels and increased thiobarbituric acid reactive substances (TBARS), superoxide dismutase (SOD), and catalase (CAT) levels in hepatic tissue (p < 0.001). Moreover, treatment groups considerably reduced hepatic inflammation, steatosis, hepatocellular ballooning, and fibrosis. These results recommend that arq ajwain has a strong protective effect against NAFLD in HFD induced obese rat models.

References:

Aftab, K., Rahman, A., Usmanghani, K., 1995. Blood pressure-lowering action of active principle from Trachyspermum ammi (L.) sprague. Phytomedicine 2(1), 35-40.
Alam, K., Nagi, M.N., Badary, O.A., O.A. Al-Shabanah, O.A., Al-Rikabi, A.C., Al-Bekairi, A.M., 1999. The protective action of thymol against carbon tetrachloride hepatotoxicity in mice. Pharmacol. Res. 40(2), 159-163.
Anonymous, 2009. National Formulary of Unani Medicine (NFUM), Government of India and Ministry of Health and Family Welfare, Department of Ayurveda, Yoga, Unani, Siddhartha and Homoeopathy (AYUSH). Part (II), Volume-1(Formulation), First Ed., pp. 07.
Arora, P., Ansari, S.H., Anjum, V., Mathur, R., Ahmad, S., 2016. Investigation of anti-asthmatic potential of Kanakasava in ovalbumin-induced bronchial asthma and airway inflammation in rats. J. Ethnopharmacol. 197 (1), 242-249.
Bairwa, R., Sodha, R.S., Rajawat, B.S., 2012. Trachyspermum ammi. Pharmacogn. Rev. 6(11), 56-60.
Caligiuri, A., Gentilini,A., Marra, F., 2016. Molecular pathogenesis of NASH. Int. J. Mol. Sci. 17(9), 2-34.
Cohen, J.C., Horton, J.D., Hobbs, H.H., 2011. Human fatty liver disease: old questions and new insights. Science 332(6037), 1519-23.
Dallio M., Sangineto, M., Romeo, M., Villani, R., Romano, A.D., Loguercio, C., Serviddio, G., Federico, A., 2021. Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression. Int. J. Mol. Sci. 22(1), 1-23.
Folch, M., Lees, G.H., Stanley, G.S.H., 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1), 497-509.
Friedewald, W.T., Levy, R.I., Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499-502
Gupta, P., Mehla, J., Gupta, Y.K., 2012. Antiobesity effect of Safoof Mohazzil, a polyherbal formulation, in cafeteria diet induced obesity in rats. Indian J. Exp. Biol. 50(11), 776-784.
Haque, M.R., Ansari, S.H., 2018. Anti-obesity effect of arq zeera and its main components thymol and cuminaldehyde in high fat diet induced obese rats. Drug Res. 68(11), 637-647.
Haque, M.R., Ansari, S.H., 2019. Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet. Human exp. Toxicol. 38(7), 823-832.
Hassan, A., Nauman, M., Anjum, F.M., Hussain, S., Nadeem, M., 2010. Comparative study on chemical composition and antioxidant activity of ginger (Zingiber officinale) and cumin (Cuminum cyminum). J. Agric. Food Chem. 58(14), 8231-8237.
Hussain, M.S., Mazumder, T., 2021. A comprehensive review of pharmacological and toxicological properties of Cheilocostus speciosus (J.Koenig) C.D.Specht. Trends Phytochem. Res. 5(1), 1-12.
Javed, I.Z., Iqbal, Z.U., Rahman, F.H., Khan, F., Muhammad, B., Aslam, L.A., 2006. Comparative antihyperlipidaemic efficacy of Trachyspermum ammi extracts in Albino rabbits. Pakistan vet. J. 26(1), 23-29.
Khan, F., Zaman, R., Shamsi, S., 2018. Accelerated stability study of arqe ajwain. Int. J. Pharm. Sci. Rev. Res. 52(1), 1-6.
Kim, J., Kim, C.S., Jo, K., Lee, I.S., Kim, J.H., Kim, J.S., 2020. POCU1b, the n-butanol soluble fraction of Polygoni cuspidati Rhizoma et Radix, attenuates obesity, non-alcoholic fatty liver, and insulin resistance via inhibitions of pancreatic lipase, cAMP-dependent PDE activity, ampk activation, and SOCS-3 suppression. Nutrients 12(12), 1-18.
Kleiner, D.E., Brunt, E.M., VanNatta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrel, L.D.l., Liu, Y.C., Torbenson, M.S., UnalpArida, A., Yeh, M., McCullough, A.J., Sanyal, A.J., 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6), 1313-1321.
Kostula, I., Mrzljak, A., Kolaric, B., Lovrencic, M.V., 2020. Leptin as a key player in insulin resistance of liver cirrhosis? A cross-sectional study in liver transplant candidates. J. Clin. Med. 9(2), 1-13.
Li, J., Sasaki, G.Y., Dey, P., Chitchumroonchokchai, C., Labyk, A.L., McDonald, J.D., Kim, J.B., Bruno, R.S., 2018. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling. J. Nutr. Biochem. 53(1), 58-65.
Manne, V., Handa, P., Kowdley, K.V., 2018. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic steatohepatitis. Clin. Liver. Dis. 22(1), 23-37.
Marklund, S., Marklund, G., 1974. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47(3), 469-474.
McCullough, A.J., Bugianesi, E., Marchesini, G., Kalhan, S.C., 1998. Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 115(4), 947-953.
Memon, R.A., Grunfeld, C., Feingold, K.R., 2001. TNF-α is not the cause of fatty liver disease in obese diabetic mice. Nat. Med. 7(1), 2-3.
Mohammadhossniei, M., Venditti, A., Frezza, C., Serafini, M., Bianco, A., Mahdavi, B., 2021. The genus Haplophyllum Juss.: Phytochemistry and bioactivities—A review. Molecules 26(15), 4664.
Mouthe Kemayou, G.P., Fotsing Kache, S., Dzouemo, L.C., M. Happi, G., Fogue Kouam, S., Tchouankeu, J.C., 2021. Phytochemistry, traditional uses, and pharmacology of the genus Ekebergia (Meliaceae): A review. Trends Phytochem. Res. 5(3), 110-125.
Nahar, L., El-Seedi, H.R., Khalifa, S.A.M., Mohammadhosseini, M., Sarker, S.D., 2021. Ruta essential oils: Composition and bioactivities. Molecules 26(16), 4766.
Ohkawa, H., Ohishi, N., Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid. Anal. Biochem. 95(2), 359-364.
Oskouei, B.G., Abbaspour-Ravasjani, S., Musavinejad, S.J., Salehzadeh, S.A., A. Abdolhosseinzadeh, A., Hamishehkar, H., Ghahremanzadeh, K., Shokouhi, B., 2018. In vivo evaluation of anti-hyperglycemic, anti-hyperlipidemic and antioxidant status of liver and kidney of thymol in STZ-induced diabetic rats. Drug Res. 69(1), 46-52. (DOI: 10.1055/a-0646-3803.
Panda, H., 2002. Handbook on Ayurvedic Medicines with Formulae, Processes & Their Uses. National Institute of Industrial Research Publisher, pp. 238-239.
Patil, S.B., Ghadyale, V.A., Taklikar, S.S., Kulkarni, C.R., Arvindekar, A.U., 2011. Insulin secretagogue, alpha-glucosidase and antioxidant activity of some selected spices in streptozotocin-induced diabetic rats. Plant Foods Human Nutr. 66(1), 85-90.
Petersen, K.F., Oral, E.A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G.W., DePaoli, A.M., Taylor, S.I., Gorden, P., Shulman, G.I., 2002. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Invest. 109(10), 1345-1350.
Rasooli A., Fatemi F., Akbarzadeh K., Dini S., Bahremand S., 2016. Synergistic protective activity of deuterium depleted water (DDW) and Satureja rechingeri essential oil on hepatic oxidative injuries induced by acetaminophen in rats. J. Essent. Oil Bear. Plants 19(5), 1086-1101.
Reagan-Shaw, S., Nihal, M., Ahmad, N., 2007. Dose translation from animal to human studies Revisited. FASEB. 22(3), 659-661.
Sepahvand, S., Amiri, S., Radi, M., Akhavan, H.R., 2021. Antimicrobial activity of thymol and thymol-nanoemulsion against three food-borne pathogens inoculated in a sausage model. Food Bioprocess Technol. 14(1), 1936-1945.
Shetty, S.N., Meng, S., Vaidya, R., Vaidya, A.D.., 2010. A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease. J Ayurveda Integr. Med. 1(3), 203-210.
Singh, G., Maurya, S., Catalan, C., De Lampasona, M.P., 2004. Chemical constituents, antifungal and antioxidative effects of ajwain essential oil and its acetone extract. J. Agric. Food Chem. 52(11), 3292-3296.
Sinha R., Lockman K.A., Homer N.Z.M., Bower E., Brinkman P., Knobel H.H., 2020. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease. JHEP Rep. 2(5), 1-10.
Srivastava, K.C., 1988. Extract of a spice--omum (Trachyspermum ammi)-shows antiaggregatory effects and alters arachidonic acid metabolism in human platelets. Prostaglandins Leukot. Essent. Fatty Acids 33(1), 1-6.
Takahashi, Y., Inaba, N., Kuwahara, S., Kuki, W., 2003. Effects of gamma-terpinene on lipid concentrations in serum using Triton WR1339-treated rats. Biosci. Biotech. Biochem. 67(11), 2448-50.
Wauters, M., Considine, R.V., Van Gaal, L.F., 2000. Human leptin: From an adipocyte hormone to an endocrine mediator. Eur. J. Endocrinol. 143(3), 293-311.
Xu, Z., Fan, J., Ding, X., Qiao, L., Wang, G., 2010. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig. Dis. Sci. 55(4), 931-940.
Yang, D.K., Jo, D., 2018. Mulberry fruit extract ameliorates nonalcoholic fatty liver disease (NAFLD) through Inhibition of mitochondrial oxidative stress in rats. Evid. Based Complement. Alternat. Med. 1(1), 1-9.
Yildiz, S.,  Turan, S.,  Kiralan, M., Ramadan, M.F., 2021. Antioxidant properties of thymol, carvacrol, and thymoquinone and its efficiencies on the stabilization of refined and stripped corn oils. J. Food Meas. Charact. 15(1), 621-632.
Zhao, S., Kusminski, C.M., Scherer, P.E., 2021. Adiponectin, leptin and cardiovascular disorders. Circulation Res. 128(1), 136-149.